The mTOR Pathway in Lung Cancer and Implications for Therapy and Biomarker Analysis

Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e31825581bd
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Clinical Cancer Drugs
Cancer ResearchToxicologyOncologyPharmaceuticsPharmacology
2016English

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Current Cancer Drug Targets
Cancer ResearchDrug DiscoveryOncologyPharmacology
2009English

Silibinin Inhibits Hypoxia-Inducible Factor-1α and mTOR/p70S6K/4E-BP1 Signalling Pathway in Human Cervical and Hepatoma Cancer Cells: Implications for Anticancer Therapy

Oncogene
Cancer ResearchGeneticsMolecular Biology
2008English

mTOR Pathway Activation Drives Lung Cell Senescence and Emphysema

JCI insight
Medicine
2018English

Rapamycin and mTOR: A Serendipitous Discovery and Implications for Breast Cancer

Clinical and Translational Medicine
MedicineMolecular Medicine
2012English

Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

MicroRNAs: A Novel Potential Biomarker for Diagnosis and Therapy in Patients With Non-Small Cell Lung Cancer

Cell Proliferation
MedicineCell Biology
2017English

P3.12-14 Genomic Profiling of Chinese Small Cell Lung Cancer and the Implications for Therapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy